On the other hand, higher expression of SERTAD1 showed significantly better outcome in relapse free survival (44.4 as compared to low expression 31) of breast cancer patients (RNA seq data set, n = 626, Logrank test p = 0.000032, HR = 0.72). Here, SERTAD1 is linked to breast carcinoma.